Literature DB >> 402665

Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.

S Magour, H Coper, C Fähndrich.   

Abstract

Rats were injected intraperitoneally once every 12 h with 10 mg/kg delta-9-THC and the time course of the depressant effect was determined after one and nine injections. The motor activity of naive rats was maximally depressed between 1 and 4 h and returned to control levels 8 h after treatment. After nine injections, the maximum intensity of the depressant effect was not different from that after one injection but had completely disappeared at an earlier time point (4 h p.i.) indicating the development of tolerance to the duration of effect on motor activity. The subcellular distribution studies in brains of tolerant and non-tolerant rats indicated that an accelerated shift in the concentrations of delta-9-THC and 11-OH-delta-9-THC towards highly polar metabolites in the brains, rather than an increased elimination of these cannabinoids or decreased sensitivity of the brain may be responsible for the development of tolerance to delta-9-THC.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402665     DOI: 10.1007/bf00431730

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.

Authors:  P F Anderson; D M Jackson; G B Chesher; R Malor
Journal:  Psychopharmacologia       Date:  1975-07-23

2.  3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs.

Authors:  B R Martin; W L Dewey; L S Harris; J S Beckner
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

3.  Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.

Authors:  S Magour; H Coper; C Fähndrich; R Hill
Journal:  Life Sci       Date:  1976-03-15       Impact factor: 5.037

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.

Authors:  A J Siemens; H Kalant
Journal:  Can J Physiol Pharmacol       Date:  1974-12       Impact factor: 2.273

6.  Marihuana on locomotor activity: biphasic effect and tolerance development.

Authors:  W M Davis; J E Moreton; W T King; H B Pace
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-01

Review 7.  Pharmacology of marijuana.

Authors:  W D Paton
Journal:  Annu Rev Pharmacol       Date:  1975       Impact factor: 13.820

8.  Studies on the effects of 1 -tetrahydrocannabinol ( 1 -THC) and DDT on the hepatic microsomal metabolism of 1 -THC and other compounds in the rat.

Authors:  D Kupfer; E Levin; S H Burstein
Journal:  Chem Biol Interact       Date:  1973-01       Impact factor: 5.192

9.  Delta-9-tetrahydrocannabinol: localization in body fat.

Authors:  D S Kreuz; J Axelrod
Journal:  Science       Date:  1973-01-26       Impact factor: 47.728

10.  Delta-9-tetrahydrocannabinol: metabolism and disposition in long-term marihuana smokers.

Authors:  L Lemberger; N R Tamarkin; J Axelrod; I J Kopin
Journal:  Science       Date:  1971-07-02       Impact factor: 47.728

View more
  2 in total

1.  Chronic delta9-tetrahydrocannabinol in rats: effect on social interactions, mouse killing, motor activity, consummatory behavior, and body temperature.

Authors:  K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1979-01-31       Impact factor: 4.530

2.  Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.

Authors:  D A Taylor; M R Fennessy
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.